Cancer thlentu vaccine research vangin dose pek tlem theih phah

Chhul hmawr cancer siamtu HPV hrik danna vaccine vawi 3 pek thin chu Mizo hmeichhia 500 leh state danga zirbingna neih a nih atangin vawi 2 pekin a thawhdan a hen tih hmuhchhuah a ni h thu sawi a ni bawk.

He thu hi Lanset Oncology 2016 lehkhabuah tihchhuah a nih thu Mizoram doctorte leh Indian Cancer Care Foundation te chuan Zalen zawhna chhangin an sawi chhuak.

ICCF hotute chuan 2009-2011 inkar khan Aizawl chhevel chhim lamah kum 10-18 inkar hmeichhia 500 te chu 250 ve vea thenin cervix cancer thlentu HPV vaccine thla 6 chhungin tih dan thin dose 3 leh zirbing nan dose 2 an pe a. India hmun hrang hrana hmeichhe 17,000 ah hetiang hian WHO hmalaknaa enchhin a ni bawk a ni. ‘ Vaccine thawh dan a in ang tih hmuh chhuah a ni a, ram dang te pawhin dose 3 pe lovin dose 2 chauh kum 9-15 inkar hmeichhiaah an pe tan tawh a, he zirbingna hian nghawng tha thui tak a nei a ni, ‘ tiin Zalen zawhna ICCF chuan an chhang a ni. 2021 hian Mizo hmeichhiate chu cancer hrik siamtu an pai leh pai loh test leh tur a nih thu Zalen an hrilh.

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Comments

Leave a Reply

Login

Lost your password?